It seems we can’t find what you’re looking for. Perhaps searching, or one of the links below, can help.
Recent Posts
- LumiThera Announces Initiation of EUROLIGHT Registry Study to Evaluate Long-term Benefits of Photobiomodulation (PBM) Treatment using the Valeda® Light Delivery System in Patients with Dry Age-Related Macular Degeneration (AMD)
- LumiThera Provides Update on FDA Review of Valeda Treatment for Dry AMD Patients
- LumiThera Receives Notice of Award for National Eye Institute Grant to Support a 3rd Year Extension to LIGHTSITE III, the U.S. Multi-Center Clinical Trial for Treating Dry Age-Related Macular Degeneration
- LumiThera Announces Sustained Vision Improvement for 24 months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial Data
- LumiThera Announces Fast Company Honors AdaptDx Pro As An Innovation and Design Award Winner
- LumiThera, Inc. Announces Purchase of MacuLogix Assets
- LumiThera Presents US LIGHTSITE III Trial Data Showing Improvement in Vision in Intermediate Dry Age-Related Macular Degeneration
- Diopsys, Inc. Announces Move to Expanded Headquarters in New Jersey
- LumiThera Announces US LIGHTSITE III Clinical Trial Meets Primary Efficacy Endpoint in Improving Vision in Dry Age-Related Macular Degeneration Subjects
- LumiThera Secures Financing to Support Commercial Activities
Most Used Categories
Archives
Try looking in the monthly archives. 🙂